Legal status · United States
Is Sermorelin legal in the United States?
Sermorelin is available in the United States only through a prescriber, classified as "Prior approval discontinued; available via compounding pharmacies". It is not sold over the counter; use sits within a clinician's judgment, not a marketing approval. Vials sold "for research use only" fall outside that route; the label does not make human use lawful. Human evidence: Moderate.
Sermorelin in the United States at a glance
| Classification | Prior approval discontinued; available via compounding pharmacies |
|---|---|
| FDA approval status | Previously FDA-approved (Geref, discontinued); available compounded |
| Evidence level | Moderate (research strength: Moderate) |
| Reviewed | Sep 2026 |
Classification and note come from the Sermorelin profile, checked against U.S. Food and Drug Administration (FDA) listings at the reviewed date.
What this means
- 01
Sermorelin reaches patients in the United States only through a prescriber, typically for a narrow labeled use or via a compounding pharmacy under a prescription.
- 02
That route depends on a clinician's judgment and, for compounded products, on the pharmacy's own quality controls rather than a product-level marketing approval.
- 03
Buying it online "for research use only" is outside that route, and the label does not make human use lawful.
What Sermorelin is
A GHRH fragment historically approved as a diagnostic and pediatric GH agent, now used in compounded anti-aging research.
Sermorelin is a synthetic version of the first 29 amino acids of GHRH, the active portion of the hormone. It was previously FDA-approved (Geref) for diagnosing and treating growth hormone deficiency, though that product was discontinued.
Mechanism: Activates pituitary GHRH receptors to stimulate physiological growth hormone release.
Regulatory history: Previously FDA-approved (Geref, discontinued); available compounded
How FDA treats this kind of product
Approves prescription drugs by indication and polices unapproved products, including peptides sold online. Compounding pharmacies may prepare some compounds under a prescription when the FDA places them on a permitted bulk-substances category.
The classification above is the The Longevity Archive reading of U.S. Food and Drug Administration listings for Sermorelin at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.
Sermorelin in other countries
Frequently asked questions
Is Sermorelin legal in the United States?
Sermorelin is available in the United States only through a prescriber, classified as "Prior approval discontinued; available via compounding pharmacies". It is not sold over the counter; use sits within a clinician's judgment, not a marketing approval. Vials sold "for research use only" fall outside that route; the label does not make human use lawful. Human evidence: Moderate.
Can I buy Sermorelin in the United States?
Only through a prescriber. In the United States Sermorelin is classified as "Prior approval discontinued; available via compounding pharmacies". There is no over-the-counter route, and products sold online "for research use only" are not the same as a prescribed, pharmacy-dispensed product.
Is Sermorelin FDA approved?
No. FDA status: Previously FDA-approved (Geref, discontinued); available compounded. Current US classification: "Prior approval discontinued; available via compounding pharmacies". Evidence level: Moderate.
Related compounds in the United States
Full research profile
Mechanism, cited studies, FDA status and the full legal summary for Sermorelin live on its compound profile.
Sermorelin profileThis page is general information about the regulatory status of Sermorelin in the United States, current as of Sep 2026. It is not legal advice, and classifications change; check U.S. Food and Drug Administration directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.